CAM
TEVA icon

Carret Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Carret Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,906
Closed -$287K – 247
2016
Q4 		$287K Sell
7,906
-253
-3% -$10.1K 0.05% 202
2016
Q3 		$375K Sell
8,159
-50
-0.6% -$2.61K 0.07% 182
2016
Q2 		$412K Hold
8,209
– – 0.08% 168
2016
Q1 		$439K Hold
8,209
– – 0.09% 155
2015
Q4 		$539K Hold
8,209
– – 0.12% 147
2015
Q3 		$463K Sell
8,209
-855
-9% -$55.4K 0.1% 157
2015
Q2 		$536K Sell
9,064
-2,150
-19% -$133K 0.11% 154
2015
Q1 		$699K Sell
11,214
-2
-0% -$116 0.14% 142
2014
Q4 		$645K Sell
11,216
-100
-0.9% -$5.57K 0.12% 151
2014
Q3 		$608K Sell
11,316
-1,000
-8% -$53K 0.12% 153
2014
Q2 		$646K Buy
12,316
+875
+8% +$44.7K 0.12% 147
2014
Q1 		$605K Sell
11,441
-55
-0.5% -$2.54K 0.12% 149
2013
Q4 		$461K Sell
11,496
-2,985
-21% -$118K 0.09% 168
2013
Q3 		$547K Sell
14,481
-13,950
-49% -$544K 0.12% 149
2013
Q2 		$1.11M Buy
+28,431
New +$1.11M 0.23% 108

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Carret Asset Management's TEVA Position: Q1 2017 in Review

Carret Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 7,906 shares — an estimated $287K sold.

Carret Asset Management first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $1.11M in Q2 2013. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Carret Asset Management reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Carret Asset Management sold 7,906 Teva Pharmaceuticals shares in Q1 2017, an estimated $287K.
  • Carret Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Carret Asset Management's Teva Pharmaceuticals position peaked at $1.11M in Q2 2013.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Carret Asset Management's 13F filing for Q1 2017, filed 9 May 2017.